Company intelligence / Profile preview
Anwita Biosciences
San Carlos, California, United Statesanwitabio.com ↗
- Ownership
- Private
- Employees
- ~49
- Development stage
- Other
01
Overview
Anwita Biosciences is advancing several Phase 1 clinical trials, including studies for Exenokine-21 and JS014, focusing on cancer and autoimmune diseases.
- Therapeutic areas
- OncologyImmunology
- Modalities
- CytokinesAntibody Drug Conjugates (ADCs)Fusion Proteins
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Shanghai Junshi Biosciences
Beyond the preview
Go deeper on Anwita Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anwita Biosciences.